BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8656011)

  • 1. Human immunodeficiency virus type 1 (HIV-1)--and Epstein-Barr virus--specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1--infected persons.
    Geretti AM; Dings ME; van Els CA; van Baalen CA; Wijnholds FJ; Borleffs JC; Osterhaus AD
    J Infect Dis; 1996 Jul; 174(1):34-45. PubMed ID: 8656011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
    Carmichael A; Jin X; Sissons P; Borysiewicz L
    J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection.
    Pontesilli O; Klein MR; Kerkhof-Garde SR; Pakker NG; de Wolf F; Schuitemaker H; Miedema F
    J Infect Dis; 1998 Oct; 178(4):1008-18. PubMed ID: 9806028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive loss of IL-2-expandable HIV-1-specific cytotoxic T lymphocytes during asymptomatic HIV infection.
    Jin X; Wills M; Sissons JG; Carmichael A
    Eur J Immunol; 1998 Nov; 28(11):3564-76. PubMed ID: 9842899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
    Klein MR; van Baalen CA; Holwerda AM; Kerkhof Garde SR; Bende RJ; Keet IP; Eeftinck-Schattenkerk JK; Osterhaus AD; Schuitemaker H; Miedema F
    J Exp Med; 1995 Apr; 181(4):1365-72. PubMed ID: 7699324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma.
    Kersten MJ; Klein MR; Holwerda AM; Miedema F; van Oers MH
    J Clin Invest; 1997 Apr; 99(7):1525-33. PubMed ID: 9119996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children.
    Luzuriaga K; Koup RA; Pikora CA; Brettler DB; Sullivan JL
    J Pediatr; 1991 Aug; 119(2):230-6. PubMed ID: 1907319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immune response to HIV-1-Nef. I. CD45RO- T lymphocytes of non-infected donors contain cytotoxic T lymphocyte precursors at high frequency.
    Lucchiari M; Niedermann G; Leipner C; Meyerhans A; Eichmann K; Maier B
    Int Immunol; 1994 Nov; 6(11):1739-49. PubMed ID: 7865467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
    van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD
    AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).
    Ferrari G; King K; Rathbun K; Place CA; Packard MV; Bartlett JA; Bolognesi DP; Weinhold KJ
    Clin Exp Immunol; 1995 Aug; 101(2):239-48. PubMed ID: 7544247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
    Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
    J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
    J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligopeptide induction of a secondary cytotoxic T-cell response to Epstein-Barr virus in vitro.
    Schmidt C; Burrows SR; Moss DJ; Sculley TB; Misko IS
    Scand J Immunol; 1991 Apr; 33(4):411-20. PubMed ID: 1708166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes.
    Lubaki MN; Egan MA; Siliciano RF; Weinhold KJ; Bollinger RC
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1427-31. PubMed ID: 7888197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytotoxic T lymphocytes. III. Large numbers of peripheral blood T cells clonally develop into allorestricted anti-viral cytotoxic T cell populations in vitro.
    Kabelitz D; Herzog WR; Heeg K; Wagner H; Reimann J
    J Mol Cell Immunol; 1987; 3(1):49-60. PubMed ID: 2855406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T-lymphocyte responses utilizing B-lymphoblastoid cell lines transduced with the CD4 gene and infected with HIV-1.
    McElrath MJ; Rabin M; Hoffman M; Klucking S; Garcia JV; Greenberg PD
    J Virol; 1994 Aug; 68(8):5074-83. PubMed ID: 8035507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus-positive individuals with oral hairy leukoplakia are able to mount cytotoxic T lymphocyte responses to Epstein-Barr virus.
    de Jong A; Palefsky JM; Stites DP; Nakagawa M
    Oral Dis; 2000 Jan; 6(1):40-7. PubMed ID: 10673787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.
    Jin X; Ogg G; Bonhoeffer S; Safrit J; Vesanen M; Bauer D; Chen D; Cao Y; Demoitie MA; Zhang L; Markowitz M; Nixon D; McMichael A; Ho DD
    Mol Med; 2000 Sep; 6(9):803-9. PubMed ID: 11071274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.
    van Baalen CA; Pontesilli O; Huisman RC; Geretti AM; Klein MR; de Wolf F; Miedema F; Gruters RA; Osterhaus AD
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1913-8. PubMed ID: 9266987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.